allogeneic transplants & graft-versus-host disease (gvhd) | dr. david miklos, stanford
Published 3 years ago • 373 plays • Length 13:34
Download video MP4
Download video MP3
Similar videos
-
9:28
david miklos, md, phd: ibrutinib in chronic graft-versus-host disease
-
38:08
allogeneic transplants and graft-versus-host disease
-
1:34
what is graft-versus-host disease (gvhd) and why does it happen?
-
4:54
graft vs. host disease (gvhd) - mayo clinic
-
13:17
mantle cell lymphoma: latest treatments | dr. david miklos, stanford | the patient story
-
1:02:35
"evolving biomarkers in kidney transplantation," presented by ast and isot
-
57:53
understanding bone marrow transplantation - from the clinical and personal perspectives
-
5:20
graft versus host disease (gvhd)
-
39:59
lymphoma, leukemia, multiple myeloma: clinical trials, car t & more | dr. david miklos, stanford
-
1:28
allogeneic ch. 18: graft-versus-host disease
-
2:12
testing an approach to reduce graft-versus-host disease
-
4:42
graft-versus-host disease
-
2:00
predicting acute graft-versus-host-disease in allogeneic stem cell transplantation patients
-
12:16
car t therapy: clinical trials and updates | dr. david miklos, stanford | the patient story
-
53:51
introduction to chronic graft-vs-host disease (gvhd) 2018
-
1:44
david miklos, md, phd, describes the optimal way to use ibrutinib in the treatment of gvhd
-
2:18
stem cell transplant: advances in graft v. host disease
-
3:27
david miklos, md, discusses the outcomes in the phase 2 ibrutinib study for chronic gvhd
-
56:20
lightning round ask the experts - clinical trials for graft-versus-host disease (gvhd) 2019
-
1:34
what is graft versus host disease? | dana-farber cancer institute
-
1:51
david miklos, md, phd, explains how ibrutinib is being studied for the treatment of gvhd
Clip.africa.com - Privacy-policy